| B cell Improve Overall Survival in HPV-Associated Squamous Cell Carcinomas and Are Acivated by Radiation and PD-1 Blockade. SAB Kim SS, Shen S, Miyauchi S, Sanders PD, Franiak-Pietryga I, Mell L ... Clinical Cancer Research 26 (13), 3345-3359, 2020 | 153 | 2020 |
| Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. CJJ Koter M, Franiak I, Strychalska K, Broncel M Int J Biochem Cell Biol 36 (2), 205-215, 2004 | 91 | 2004 |
| The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. FI Koter M, Broncel M, Chojnowska-Jezierska J, Klikczynska K Eur J Clin Pharmacol. 58 (8), 501-506, 2002 | 75 | 2002 |
| All that glitters is not silver—a new look at microbiological and medical applications of silver nanoparticles P Kowalczyk, M Szymczak, M Maciejewska, Ł Laskowski, M Laskowska, ... International Journal of Molecular Sciences 22 (2), 854, 2021 | 60 | 2021 |
| The influence of maltotriose-modified poly (propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI I Franiak-Pietryga, E Ziółkowska, B Ziemba, D Appelhans, B Voit, ... Molecular Pharmaceutics 10 (6), 2490-2501, 2013 | 43 | 2013 |
| Dendrimers as drug nanocarriers: the future of gene therapy and targeted therapies in cancer I Franiak-Pietryga, B Ziemba, B Messmer, D Skowronska-Krawczyk Dendrimers: fundamentals and applications 25, 7, 2018 | 41 | 2018 |
| Toxicity and proapoptotic activity of poly (propylene imine) glycodendrimers in vitro: Considering their contrary potential as biocompatible entity and drug molecule in cancer B Ziemba, I Franiak-Pietryga, M Pion, D Appelhans, ... International journal of pharmaceutics 461 (1-2), 391-402, 2014 | 39 | 2014 |
| Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. CJJ Koter M, Franiak I, Broncel M Can J Physiol Pharmacol. 81 (5), 485-92, 2003 | 31 | 2003 |
| Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy DV Hingorani, MM Allevato, MF Camargo, J Lesperance, MA Quraishi, ... Nature communications 13 (1), 3869, 2022 | 28 | 2022 |
| Anti-inflammatory and hypolipemic effects in vitro of simvastatin comparing to epicatechin in patients with type-2 hypercholesterolemia I Franiak-Pietryga, M Koter-Michalak, M Broncel, P Duchnowicz, ... Food and Chemical Toxicology 47 (2), 393-397, 2009 | 24 | 2009 |
| Erythrocyte fluidity in patients with hyperlipidemia during statins therapy. FI Broncel M, Chojnowska Jezierska J, Koter-Michalak M Polskie Archiwum Medycyny Wewnetrznej/Polish Archives of Internal Medicine …, 2005 | 23* | 2005 |
| Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway I Franiak-Pietryga, H Maciejewski, K Ostrowska, D Appelhans, B Voit, ... International Journal of Biological Macromolecules 88, 156-161, 2016 | 22 | 2016 |
| PPI‐G4 Glycodendrimers Upregulate TRAIL‐Induced Apoptosis in Chronic Lymphocytic Leukemia Cells I Franiak‐Pietryga, K Ostrowska, H Maciejewski, D Appelhans, ... Macromolecular Bioscience 17 (5), 1600169, 2017 | 20 | 2017 |
| PPI-G4 glycodendrimers upregulates TRAIL-induced apoptosis in chronic lymphocytic leukemia cells. BM Franiak-Pietryga I, Ostrowska K, Maciejewski H, Appelhans D, Misiewicz M ... Macromolecular Bioscience, DOI: 10.1002/mabi.201600169, 2016 | 20* | 2016 |
| Neurotoxicity of poly (propylene imine) glycodendrimers I Franiak-Pietryga, B Ziemba, H Sikorska, M Jander, D Appelhans, ... Drug and Chemical Toxicology 45 (4), 1484-1492, 2022 | 17 | 2022 |
| Activated B cells and plasma cells are resistant to radiation therapy I Franiak-Pietryga, S Miyauchi, SS Kim, PD Sanders, W Sumner, L Zhang, ... International Journal of Radiation Oncology* Biology* Physics 112 (2), 514-528, 2022 | 15 | 2022 |
| Maltotriose-modified poly (propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in … I Franiak-Pietryga, B Ziemba, H Sikorska, M Jander, W Kuncman, ... Toxicology and Applied Pharmacology 403, 115139, 2020 | 13 | 2020 |
| Blockage of Wnt/β‐Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro—Preliminary Study I Franiak‐Pietryga, H Maciejewski, B Ziemba, D Appelhans, B Voit, ... Macromolecular Bioscience 17 (11), 1700130, 2017 | 12 | 2017 |
| Glycodendrimer PPI as a potential drug in chronic lymphocytic leukaemia. The influence of glycodendrimer on apoptosis in in vitro B-CLL cells defined by microarrays I Franiak-Pietryga, E Ziolkowska, B Ziemba, D Appelhans, H Maciejewski, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 12 | 2017 |
| The influence of bendamustine used either alone or in combination with purine nucleoside analogues on the viability and apoptosis of chronic lymphocytic leukemia cells in … A Zaborowska, B Cebula-Obrzut, I Franiak-Pietryga, JZ Błoński, ... Acta. Haematol. Pol 40, 781-791, 2009 | 12 | 2009 |
Henryk MaciejewskiWroclaw Univ. of TechnologyVerified email at pwr.edu.pl